The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

IMM IMMUPHARMA PLC ORD 10P




Time/Date Code Headline Source Impact
12:22 05-Feb-2016 IMM Placing and Subscription Raises 8.3 million RNS -13.37% Down
07:00 05-Feb-2016 IMM Proposed Placing and Subscription RNS -13.37% Down
17:33 21-Jan-2016 IMM Holding(s) in Company RNS +14.53% Up
07:00 15-Dec-2015 IMM ImmuPharma & Simbec-Orion - Investigators Meeting RNS +6.73% Up
07:00 07-Dec-2015 IMM Update on the progress of Lupuzor RNS +28.61% Up
11:55 30-Nov-2015 IMM Holding(s) in Company RNS -7.24% Down
08:26 04-Nov-2015 IMM Lupuzor Phase III Pivotal Trial Update RNS +0.97% Up
07:00 04-Nov-2015 IMM Lupuzor Phase III Pivotal Trial Update RNS +0.97% Up
07:00 23-Oct-2015 IMM Directorate Change RNS -10.03% Down
07:05 30-Sep-2015 IMM Directorate Change RNS -4.46% Down
07:00 30-Sep-2015 IMM Interim Results RNS -4.46% Down
07:00 29-Jul-2015 IMM Richard Warr RNS +5.86% Up
07:00 27-Jul-2015 IMM TERM SHEET SIGNED $14 MILLION FUNDING FOR LUPUZOR RNS +10.64% Up
07:00 25-Jun-2015 IMM Lupuzor's Founder Dr Slyviane Muller Awarded Medal RNS -3.91% Down
12:50 29-May-2015 IMM Result of AGM RNS +1.44% Up
15:44 06-May-2015 IMM Annual Report & Accounts RNS -3.60% Down
07:02 06-May-2015 IMM Interim Board Change RNS -3.60% Down
07:05 30-Apr-2015 IMM Directorate Change RNS -3.88% Down
07:00 30-Apr-2015 IMM Preliminary Results RNS -3.88% Down


Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.





Company Information
Updated Monthly
Company address 50 Broadway, Westminster, London, SW1H 0BL, United Kingdom
Company website http://www.immupharma.c...
Market cap(in millions)* £ 21.60
Listing/Admission to trading 17 Feb 2006
Trading service SETSqx
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
12-Feb-16
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment ASQ1
MiFID Status MTF
Exchange market size 10,000
SEDOL 3371101
ISIN number GB0033711010



IMMUPHARMA share news analysis (IMM)